Effect of serum type and concentration on the expression of β-galactosidase in recombinant vaccinia virus infected HeLa S3 cells

Cytotechnology: International Journal of Cell Culture and Biotechnology

Volumn 19, Issue 2, 1995, Pages 153-159

  Jun, Seung Chul ^a   Lee, Gyun Min ^a   Chang, Su Hwan ^a   Kim, Jung Hoe ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

calf and horse serum; HeLa S3 cells; vaccinia virus; galactosidase

Indexed keywords

EID: 0029548455     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/BF00749770     Document Type: Article

References (23)

1. Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity
2. Role of cell-associated enveloped vacinia virus in cell-to-cell spread
3. Poxvirus pathogenesis
4. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques
5. Further investigations on the mode of entry of vaccinia virus into cells
6. Propagation of recombinant vaccinia virus in HeLa cells: adsorption kinetics and replication in batch cultures
7. Preparation of cell cultures and vaccinia virus stocks
8. High level expression of active human prothrombin in a vaccinia virus expression system
9. Studies on the mechanism of entry of vaccinia virus in animal cells
10. Manipulation of vaccinia virus vectors
11. Vaccinia virus: a versatile tool for molecular biologists
12. Poxviridae and their replication
13. Regulation of vaccinia virus transcription
14. Vaccinia virus: a tool for research and vaccine development
15. Physiological factors of growth and susceptibility to virus regulating Vero cells for optimum yield of vaccinia and cloned gene product (β-hCG)
16. Adsorption and penetration of enveloped and naked vaccinia virus particles
17. Enteric adenovirus 41 (Tak) requires low serum for growth in human primary cells
18. Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions
19. Comparison of cell disruption methods for determining β-galactosidase activity expressed in animal cells
20. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen
21. Recombinant vaccinia virus vaccines
22. Expression and cell type-specific processing of human preproenkephalin with a vaccinia recombinant
23. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system